Skip to main content
Rachna T Shroff on Muck Rack

Rachna T Shroff

As seen in: Nature, JAMA Oncology, Medscape, The Lancet, HemOnc Today, NewsBreak, Chinese Clinical Oncology, ONCOLOGY journal, CURE Magazine, OncLive and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rachna T

Contact Rachna T, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Real-World Outcomes With Atezolizumab Plus Bevacizumab vs Durvalumab-Based Therapy

|
By Rachna T Shroff, James Harding Verified, Lipika Goyal
| ONCOLOGY journal Verified
Opinion|Videos|July 17, 2026 Author(s)Rachna T. Shroff, MD, MS, FASCO, James J. Harding, MD, Lipika Goyal, MD Midhun Malla, MD, presents real-world data for Team Deep-Dish Pizza, reviewing a multicenter retrospective study comparing frontline atezolizumab plus bevacizumab with durvalumab-based therapy in advanced hepatocellular carcinoma (HCC).
Open in Who Shared View Duplicates (4) Issue with article?

Overcoming PD-1 Resistance in Relapsed/Refractory Hodgkin Lymphoma

|
By Guilherme Fleury Perini, Rachna T Shroff, James Harding Verified
| ONCOLOGY journal Verified
At the 2026 European Hematology Association (EHA) Congress, long-term data from the phase 2 KEYFORM-008 trial (NCT05508867) were presented by Guilherme Perini, MD, PhD, first author of the study and investigator at Instituto Américas and Einstein Hospital Israelita in São Paulo, Brazil, who shed light on a novel approach for managing classic Hodgkin lymphoma that has grown resistant to standard PD-1 blockade.
Open in Who Shared Issue with article?

Opening Remarks and the Frontline Treatment Landscape in Advanced HCC

|
By Sherry Shen, Rachna T Shroff, James Harding Verified
| ONCOLOGY journal Verified
9th Annual School of Nursing Oncology™ Beth Faiman, PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO; Beth Sandy, MSN, CRNP, FAPO; Lindsay Adkins, MSN, FNP-BC, BMTCN; Jeneth Aquino, DNP, FNP-BC; Casey Gormley, MSN, FNP-C, AOCNP; Heather J. Jackson, PhD, FNP-BC; Kelsey Martin, AG-ACNP-BC, AOCNP; Nerina T. McDonald, PA-C; Lauren Verity Moore, DNP, MSN, AGACNP-BC; Faith A.
Open in Who Shared View Duplicates (6) Issue with article?
See all 39 licensed articles (100 Total)